Article info
PDFShort report
Evaluation of cell-line-derived xenograft tumours as controls for immunohistochemical testing for ER and PR
- Correspondence to Dr K R Kao, IHC Lab, Division of Anatomical Pathology, Laboratory Medicine Program, Eastern Health, 300 Prince Philip Drive, St John's, Newfoundland, Canada A1B 3V6; kkao{at}mun.ca
Citation
Evaluation of cell-line-derived xenograft tumours as controls for immunohistochemical testing for ER and PR
Publication history
- Received April 11, 2015
- Revised May 25, 2015
- Accepted May 26, 2015
- First published June 19, 2015.
Online issue publication
August 11, 2020
Article Versions
- Previous version (15 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions